2026 ICD-10-CM Diagnosis Code C96.AHistiocytic sarcoma
ICD-10-CM Codes›C00–D49›C81-C96›C96
- Billable — Valid for Submission
- Chronic Condition
C96.A is a billable ICD-10-CM diagnosis code for histiocytic sarcoma. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 820 through 825, 840 through 842. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Sarcoma.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Fibroblastic reticular cell neoplasm
- Histiocytic sarcoma
- Malignant histiocytic disorder
- Malignant histiocytosis
- Malignant histiocytosis involving skin
- Malignant histiocytosis of intra-abdominal lymph nodes
- Malignant histiocytosis of intrapelvic lymph nodes
- Malignant histiocytosis of intrathoracic lymph nodes
- Malignant histiocytosis of lymph nodes of axilla and upper limb
- Malignant histiocytosis of lymph nodes of head
- Malignant histiocytosis of lymph nodes of head and neck
- Malignant histiocytosis of lymph nodes of lower limb
- Malignant histiocytosis of lymph nodes of multiple sites
- Malignant histiocytosis of lymph nodes of neck
- Malignant histiocytosis of lymph nodes of upper limb
- Malignant histiocytosis of spleen
- Neoplasm of intra-abdominal lymph nodes
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Malignant histiocytosis
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Arthropathy - See Also: Arthritis; - M12.9
- malignant histiocytosis - C96.A
- Histiocytosis - D76.3
- malignant - C96.A
- Lymphoma (of) (malignant) - C85.90
- histiocytic - C85.9
- true - C96.A
- true histiocytic - C96.A
- histiocytic medullary - C96.A
- Sarcoma (of) - See Also: Neoplasm, connective tissue, malignant;
- histiocytic - C96.A
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Arthropathy
- in (due to)
- malignant histiocytosis
- Histiocytosis
- malignant
- Lymphoma(of) (malignant)
- histiocytic
- true
- Lymphoma(of) (malignant)
- true histiocytic
- Reticulosis(skin)
- histiocytic medullary
- Sarcoma(of)
- histiocytic
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Histiocytic Sarcoma
malignant neoplasms composed of macrophages or dendritic cells. most histiocytic sarcomas present as localized tumor masses without a leukemic phase. though the biological behavior of these neoplasms resemble lymphomas, their cell lineage is histiocytic not lymphoid.
Convert C96.A to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About C96.AOverview
Is C96.A a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report histiocytic sarcoma on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does C96.A group to?
When histiocytic sarcoma is the principal diagnosis on an inpatient stay, it groups to MS-DRG 820, 821, 822, 823, 824, 825, 840, 841, 842, with relative weights from 1.0104 to 5.8648 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of C96.A?
Under the General Equivalence Mappings, histiocytic sarcoma converts to ICD-9-CM 202.30 (mlg hist unsp xtrndl org). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
